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Abstract 
D-glucose regulates maintenance and function of pancreatic β-cells. Several studies 
have shown that IRS-2, but not IRS-1, is necessary to maintain and sufficient to 
expand functional β-cell mass. We therefore analyzed the expression of IRS-2 and 
IRS-1 in β-cells after culture in the presence of various concentrations of D-glucose 
and other metabolisable or non-metabolisable hexoses. D-glucose increased Irs-2 
transcription and IRS-2 accumulation in a dose-dependent manner (1.6 to 25 mmol/l), 
with a 3-fold increased plateau after 10 h. In contrast, the expression of IRS-1 
remained unaffected. D-glucose also induced phosphorylation of IRS-2 while non-
metabolisable hexoses did neither affect expression nor phosphorylation. D-glucose-
mediated elevation and phosphorylation of IRS-2 were independent of autocrine 
insulin action although insulin itself could transiently and slightly enhance IRS-2 
expression.  
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Introduction 
Although impaired peripheral insulin sensitivity is thought to be the primary 
cause for type 2 diabetes, it has been recognized that pancreatic β-cells can prevent 
the onset of overt hyperglycemia by secreting compensatory amounts of insulin. β-
cell mass is regulated through changes in cell number and size by humoral, neural and 
intraislet factors (Bernard-Kargar and Ktorza, 2001; Bonner-Weir, 2000). Despite its 
chronically toxic effect D-glucose and some other hexoses are among the most potent 
stimulators of β-cell proliferation (Bonner-Weir et al., 1989; King and Chick, 1976; 
King et al., 1978; Swenne, 1992). On the other hand, studies with homo- and 
heterozygous knock-out mice have revealed that IRS-2 is required for maintenance of 
β-cell mass (Kubota et al., 2000; Withers et al., 1999; Withers et al., 1998). Elevated 
levels of IRS-2 in islets were found to prevent diabetes in animal models (Hennige et 
al., 2003). Our own recent work shows that overexpression of IRS-2 in isolated 
pancreatic islets is sufficient to induce proliferation and protect human β-cells from 
D-glucose induced apoptosis (Mohanty et al., 2005).  
D-glucose acts synergistically with mitogens such as GH and IGF-I (Cousin et 
al., 1999; Hügl et al., 1998) which are both known to recruit IRS proteins for signal 
transduction. Studies by Jahla and co-workers (Jhala et al., 2003) suggest that D-
glucose increases cytosolic concentrations of cAMP and Ca2+ and thereby activates 
transcription of Irs-2 via cAMP response element binding protein (CREB). However, 
the direct link between D-glucose and the regulation of IRS-2 biosynthesis remains to 
be elucidated.  
In order to refine the current picture we determined the expression of IRS-2 in 
β-cells after stimulation with D-glucose, ex vivo. We demonstrate that the 
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metabolisable hexoses D-glucose and D-mannose but not the inert L-glucose, D-
galactose and D-fructose increase the expression and phosphorylation of IRS-2 in 
islets and INS-1 cells. IRS-1 remained unaffected by hexose stimulation. D-glucose 
upregulated the expression of Irs-2 mRNA after 30 minutes while the increase in IRS-
2 protein content was observed with a delay of 2 hours. IRS-2 protein levels remained 
elevated for at least 48 hours.  
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Materials and Methods 
Chemicals and antibodies 
RPMI-1640 and cell culture reagents were purchased from Life Technologies 
(Basel, Switzerland). Human insulin was a gift from Novo Nordisk (Bagsvaerd, 
Denmark). Collagenase P (Clostridium histolyticum) was purchased from Roche 
(Rotkreuz, Switzerland). [32P]-deoxycytidine triphosphate was obtained from 
Amersham Pharmacia Biotech (UK). Polyclonal antibodies against IRS-2 and β-actin, 
and a monoclonal antibody against phosphotyrosine were from Santa Cruz 
Biotechnology (USA). An antibody against a C-terminal peptide of human IRS-1 was 
generated in rabbits. Peroxidase-conjugated secondary antibodies were from Bio-Rad 
(Glattbrugg, Switzerland).  
Cell culture 
INS-1 cells (passages 83-95) were cultured in RPMI-1640 containing 11 mmol/l 
D-glucose, 10% (v/v) heat inactivated fetal calf serum, 2 mmol/l L-glutamine, 50 
μg/ml gentamycin, 1 mmol/l sodium pyruvate, 10 mmol/l HEPES (pH 7.3), and 50 
μmol/l β-mercaptoethanol, at 37°C, under 5% CO2 in a humidified atmosphere 
(Asfari et al., 1992). 1 x 106 cells per 20-cm2-surface dish were pre-cultured in the 
presence of 11 mmol/l D-glucose for 3 days to about 80 % confluence prior to the 
experiments. Glucose deprivation was in supplemented RPMI-1640 containing 1.6 
mmol/l D-glucose for 24 h or as specified. A concentration of 1.6 mmol/l of D-
glucose was chosen because β-cells are especially sensitive to culture conditions 
without D-glucose. Long starvation times up to 24 h at 1.6 mmol/l D-glucose were 
preferred to allow expression of target proteins to reach basal levels. 
Isolation and culture of rat islets 
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Islets of Langerhans were isolated from 5 days old Zur:SIV rats by collagenase 
digestion of the pancreas followed by separation on Percoll gradients (Yamamoto et 
al., 1981). Three batches of approximately 100 islets were handpicked and precultured 
for 5 days in RPMI-1640 containing 11 mmol/l D-glucose and 10% newborn calf 
serum prior to glucose deprivation at 3.3 mmol/l D-glucose for 6 h. 
Immunoblot analysis 
INS-1 cells were lysed in ice-cold lysis buffer consisting of 50 mmol/l HEPES 
(pH 7.5), 140 mmol/l NaCl, 0.5% (v/v) Triton X-100, 1 mmol/l phenylmethylsulfonyl 
fluoride, 3 μg/ml leupeptin, 3 μg/ml aprotinin, 10 mmol/l sodium fluoride, 1 mmol/l 
disodium pyrophosphate, and 1 mmol/l sodium orthovanadate. Islets were collected in 
the same lysis buffer but without Triton X-100 and disrupted by multiple strokes of 
sonication. Thereafter, Triton X-100 was added to 2% (v/v) for complete protein 
extraction. Protein concentrations were determined with the bicinchoninic acid assay 
(Pierce, Rockford, IL). 5 μg INS-1 protein extract, and 20 μg islets extract, 
respectively, were subjected to SDS-polyacrylamide gel electrophoresis (Laemmli, 
1970) and transferred onto nitrocellulose membranes (Protran BA 85, Schleicher and 
Schuell). Signals were visualized by enhanced chemiluminiscence (ECL, Amersham 
Life Science, UK) and quantified densitometrically.  
Northern blot analysis 
INS-1 cells were seeded onto 150 cm2 dishes and cultured for 3 days. Total 
cellular RNA was isolated (Chomczynski and Sacchi, 1987), electrophoresed through 
agarose-formaldehyde gels and transferred to nylon membranes (Hybond-NX-RPK 
5020 - Amersham Life Science, UK). 32P-labelled DNA probes complementary to 
murine IRS-2 (Sun et al., 1995) and human β-actin (Alonso et al., 1986) were 
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hybridized at 42°C (Amasino, 1986). Specific activity of the probes was around 2 x 
109 cpm/μg. Blots were analyzed in a phosphoimager (FUJIX BAS2000).  
Insulin determination 
Accumulated insulin in the cell supernatant was determined by a competitive 
ELISA using rat insulin as standard with a detection limit of 0.1 ng/ml (Kekow et al., 
1988; Webster et al., 1990). 
Results 
D-glucose enhances accumulation of IRS-2, but not of IRS-1 in pancreatic β-cells 
To assess if D-glucose concentration affects the accumulation of IRS-1 and 
IRS-2 in β-cells the insulinoma-derived β-cell line INS-1 was glucose deprived (for 
details see materials and methods) prior to exposure to 16 mmol/l D-glucose for up to 
24 h. Incubation at 16 mmol/l D-glucose did not alter IRS-1 content whereas IRS-2 
was increased up to 3-fold relative to actin (Fig. 1A). Moreover, the increase in IRS-2 
was accompanied by post-translational modification(s) as reflected by a delay in 
protein mobility on SDS-PAGE (lanes 3, 5 and 7). Fig. 1C shows that this shift was 
lost after incubation of lysates with alkaline phosphatase or omitting phosphatase 
inhibitors during cell lysis. In contrast, the migration of IRS-1 protein was unaffected 
by D-glucose. 
To test whether D-glucose can also affect IRS-2 expression in primary β-cells, 
isolated rat islets were used. As shown in Fig. 1B, after exposure for 6 h to 20 mmol/l 
D-glucose, islets and INS-1 β-cells responded similarly and both showed significantly 
increased IRS-2 content. Despite extended efforts and as described by others 
(Schuppin et al., 1998), IRS-1 levels in rat islets remained below our detection limit 
(not shown). Based on these observations we consider the insulinoma-derived INS-1 
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cell line as representative for pancreatic β-cells and all further experiments were 
performed in this model cell line. 
 
Glucose enhances Irs-2 transcription and protein accumulation in a time and 
dose dependent manner 
Northern blot analysis revealed that steady-state levels of Irs-2 mRNA 
increased slightly in the presence of 16 mmol/l D-glucose within a period of 4 h 
compared to actin. (Fig. 2A). Irs-2 mRNA increased prior to IRS-2 protein (compare 
Fig. 1A and 2B with Fig. 2A).  
IRS-2 protein levels reached an elevated plateau after 6 to 10 h exposure to 16 
mmol/l D-glucose and remained elevated for the entire investigated period of 48 h 
(Fig. 2B). In contrast, the extent of IRS-2 post-translational modification was 
transient with a peak at 10 h, after which it slowly declined. Culturing cells in the 
presence of D-glucose ranging from 5.5 mM to 25 mM resulted in increasingly higher 
levels of IRS-2 (Fig. 2C).  
 
Hexoses need to be metabolized to increase IRS-2 protein accumulation 
The biologically inert L-glucose did neither affect cellular IRS-2 content nor its 
posttranslational modification at 14.4 mmol/l when present at basal levels of 1.6 
mmol/l D-glucose for up to 18 h (Fig. 3A). This finding rules out that increased 
osmolarity affected IRS-2 expression as observed for other genes (Okazaki et al., 
1997). Furthermore, we tested other metabolisable and non-metabolisable hexoses at 
concentrations of 14.4 mmol/l supplemented with 1.6 mmol/l D-glucose to a total 
hexose concentration of 16 mmol/l. Like D-glucose, also D-mannose increased IRS-2 
levels (Fig. 3B, lanes 2, 4, 8, and 10) whereas the metabolically inert D-galactose and 
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D-fructose (Ashcroft, 1980) did neither increase IRS-2 content nor affect its 
posttranslational modification (Fig. 3B, lanes 3, 5, 6, 9, 12, and 13). Finally, the non-
glycolytic glucose analogues 2-deoxy-D-glucose and 3-0-methyl-glucose (Ashcroft et 
al., 1973) did not enhance IRS-2 biosynthesis at total hexose concentrations of 16 
mmol/l in a period of 24 h (Fig. 3C, lanes 2 and 3).  
 
Insulin enhances IRS-2 expression but does not act as a long-term mediator for 
D-glucose 
Since D-glucose induces insulin secretion from β-cells autocrine insulin action 
could mediate the effect of D-glucose on Irs-2 expression. First we tested if insulin 
itself increases IRS-2 protein accumulation in INS-1 cells. Fig. 4A shows that 100 
nmol/l insulin transiently enhances cellular IRS-2 content, but to a much lesser extent 
than 16 mmol/l D-glucose. However, the insulin concentration used in these 
experiments was supraphysiological (see Fig. 4C for comparison). Therefore we 
challenged INS-1 cells with 16 mmol/l D-glucose and with 100 nmol/l insulin 
simultaneously or individually and found (Fig. 4B) that D-glucose increased 
expression and phosphorylation of IRS-2 in the presence of 100 nmol/l insulin. In 
addition, we preincubated INS-1 cells in the presence of 250 μmol/l diazoxide prior to 
a D-glucose challenge. Diazoxide blocked glucose-induced insulin secretion (Fig. 
4C), however, this did not attenuate the glucose-induced increase of IRS-2 
accumulation and phosphorylation (Fig. 4C).  
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Discussion 
Functional β-cell mass can increase to compensate for insulin resistance and 
thereby prevents the onset of overt hyperglycemia (Bonner-Weir, 2000). However, 
with time β-cells often fail and type 2 diabetes develops (Leahy and Weir, 1991; Ling 
et al., 1996). Hyperglycemia exerts dual and opposing effects on β-cells. Chronically 
elevated glucose levels result in pathological protein glycosylation, enhanced Fas-
receptor expression and superoxide-mediated activation of uncoupling protein 2 (Liu 
et al., 2000; Maedler et al., 2001; Ristow et al., 2003). On the other hand, glucose 
stimulates β-cell growth and has been found to be anti-apoptotic (Bonner-Weir, 2000; 
Bonner-Weir et al., 1989; Hoorens et al., 1996). These opposing effects of D-glucose 
could depend on IRS-2 levels in β-cells. Various reports have shown that Irs-2 is 
required for the maintenance of β-cell mass in vivo. We have shown previously that 
upregulation of IRS-2 in isolated islets stimulates β-cell proliferation and inhibits D-
glucose-induced apoptosis (Mohanty et al., 2005). Furthermore, D-glucose and IGF-I 
synergistically increase proliferation of β-cells. (Kubota et al., 2000; Withers et al., 
1999; Withers et al., 1998). The present study provides further evidence that IRS-2 is 
the link between D-glucose and its effects on β-cells.  
We found that D-glucose upregulates transcription of Irs-2 and increases IRS-2 
protein levels for at least 48 hours while Irs-1 remained unaffected. This finding 
correlates well with reports showing D-glucose-induced β-cell growth to last for 96 h 
in hyperglycemic rats (Bonner-Weir et al., 1989). Our observations also support 
previously published data (Jhala et al., 2003) that showed D-glucose-dependent 
activation of the transcription factor CREB which can bind to a cAMP response 
element (CRE) in the IRS-2 promoter. However, our results directly link D-glucose 
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and IRS-2 levels in β-cells. We could confirm that D-glucose induces phosphorylation 
of CREB at Ser133 within 3-5 minutes and so did insulin (not shown), but only D-
glucose induced sustained upregulation of IRS-2. Thus, activation of CREB at Ser133 
might not be sufficient for a prolonged and strong increase of IRS-2 levels.  
A new and original finding of the present study is that only metabolisable 
hexoses can increase cellular IRS-2 content. Metabolic inert hexoses and analogues of 
D-glucose were ineffective (Fig. 3). Thus, neither hexose translocation through 
glucose transporters (3-0-methyl-glucose) nor the initial phosphorylation by 
hexokinase (2-deoxy-D-glucose) were sufficient to enhance IRS-2 accumulation 
indicating that the trigger for IRS-2 accumulation requires glycolysis.  
Incubation of INS-1 cells at elevated concentrations of metabolisable hexoses 
induced a transient phosphorylation of IRS-2 but not IRS-1. This raises the question 
which kinase(s) is(are) involved. Since D-glucose was able to induce phosphorylation 
of IRS-2 even if endogenous insulin secretion was prevented with diazoxide, the 
tyrosine kinases of the insulin and IGF-I receptor, respectively, are unlikely to be the 
mediators of this effect. We therefore suggest that metabolisable hexoses induce 
cytosolic kinases that are known to phosphorylate IRS proteins, such as protein kinase 
C (PKC), JNK or mammalian target of rapamycin (mTOR) (for review see (Pirola et 
al., 2004)). Indeed, a recent study has identified IRS-2 as a target of mTOR-dependent 
Ser/Thr phosphorylation in INS-1 cells (Briaud et al., 2004). These authors show that 
chronically elevated D-glucose concentrations can induce proteosomal degradation of 
IRS-2 which points to a possible mechanism underlying glucotoxicity. However, the 
mechanisms underlying this switch from upregulation to degradation of IRS-2 in β-
cells by elevated D-glucose concentrations remain to be determined. It is conceivable 
that ER-stress-dependent activation of c-Jun N-terminal kinase (JNK) plays a role. A 
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recent study shows that obesity-induced ER-stress can repress IRS proteins in liver 
and fat (Ozcan et al., 2004). In addition, ER-stress-induced apoptosis and β-cell 
failure is a long discussed concept that could underlie hyperglycemia-induced β-cell 
exhaustion (Oyadomari et al., 2002). We are currently investigating the intracellular 
mechanisms, which lead to upregulation and phosphorylation of IRS-2 by D-glucose.  
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Figure Legends 
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Fig. 1. D-glucose increases IRS-2, but not IRS-1 protein accumulation and 
phosphorylation in β-cells. IRS-1 and IRS-2 levels were assessed in lysates from 
INS-1 cells or pancreatic rat islets by Western blot analysis (A) INS-1 cells were D-
glucose deprived at 1.6 mmol/l for 24 h before D-glucose was increased to 16 mmol/l 
for the indicated times. (B) INS-1 cells, and approximately 100 rat islets, were D-
glucose deprived at 3.3 mmol/l for 6 h before D-glucose was increased to 20 mmol/l 
for additional 6 h. The presented immunoblots are representative of three independent 
experiments. (C) Cell lysates from glucose-deprived (1.6 mmol/l) or glucose-
stimulated (16 mmol/l) INS-1 cells were prepared with (lane 1 and 4) or without 
phosphatase inhibitors (2, 3, 5 and 6). In addition, two lysates (3 and 6) were exposed 
to alkaline phosphatase at 37° C for 30 min. 
 
Fig. 2. D-glucose elevates IRS-2 transcript and protein content in a time- and 
dose-dependent manner. (A) Glucose deprived INS-1 cells were exposed to either 
1.6 or 16 mmol/l D-glucose for 0, 15, 30 min, and 1, 2 and 4 h, respectively. Total 
RNA was isolated and the expression of Irs-2 and actin mRNAs was assessed by 
Northern blotting. Each lane contains 15 μg of total RNA. Signal intensities of IRS-2 
(top) and β-actin (middle) were quantified using a phosphoimager. The lower panel 
shows ethidium bromide-staining of 18S rRNA. The relative abundance of IRS-2 
compared to actin is indicated below the autoradiographs. (B) Glucose deprived INS-
1 cells were exposed to 16 mmol/l D-glucose for up to 48 h before IRS-2 abundance 
was assayed on immunoblots. (D) INS-1 cells were exposed for 24 h to 1.6, 5.5, 11.0, 
or 25.0 mmol/l D-glucose, respectively, before IRS-2 abundance was assayed on 
immunoblots. 
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Fig. 3. Metabolisable hexoses stimulate IRS-2 accumulation in a dose- and time-
dependent manner in INS-1 cells. IRS-2 levels were determined in lysates from 
hexose-induced INS-1 cells by immunoblotting. (A) 14.4 mmol/l D-or L-glucose were 
added for the indicated times to INS-1 cells after culturing in 1.6 mmol/l D-glucose. 
(B) INS-1 cells were deprived at 1.6 mmol/l D-glucose for 24 h before exposure for 
10 or 24 h to additional 14.4 mmol/l D-glucose (lanes 2, 8), L-glucose (3, 9), D-
mannose (4, 10), D-galactose (5, 11), and D-fructose (6, 12), respectively, or 
maintained at 1.6 mmol/l glucose (1, 7, 13, 14). (C) INS-1 cells were cultured at 1.6 
mmol/l D-glucose before they were exposed for 10 h to additional 14.4 mmol/l 2-
deoxy-D-glucose (lane 2), 3-0-methyl-glucose (3), and D-glucose (4), respectively, or 
maintained at 1.6 mmol/l D-glucose (1). 
 
Fig. 4. Insulin enhances the expression of IRS-2 in INS-1 cells but does not act as 
a mediator for D-glucose. (A, B and C) Cells were cultured in 1.6 mmol/l D-glucose 
for 16 h. Thereafter, the medium was adjusted to the indicated conditions. Lysates 
were analysed by Western blotting. (A) Comparison of IRS-2 expression after 
stimulation with 16 mmol/l D-glucose or with 100 nmol/l insulin in the presence of 
1.6 mmol/l D-glucose. (B) Comparison of IRS-2 expression after stimulation with 16 
mmol/l D-glucose alone or with 100 nmol/l insulin in the presence of either 1.6 or 16 
mmol/l D-glucose. (C) Glucose-deprived INS-1 cells were either maintained at 1.6 
mmol/l D-glucose or were exposed to 16 mmol/l D-glucose in the presence or absence 
of 250 mol/l diazoxide to suppress insulin secretion. The accumulated insulin 
concentrations in supernatant at the end of the stimulation periods are indicated below 
the corresponding lanes. 
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